The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).Guidelines on diabetes, pre-diabetes and cardiovascular diseases: executive summary. Eur Heart J2007;28:88-136.
2.
The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).Guidelines on diabetes, pre-diabetes and cardiovascular diseases: full text. www.escardio.organdwww.easd.org (Accessed April 2007).
3.
De Backer G. , Ambrosiomi E., Borch-Johnsen K., et al. Third joint task force of the European and other societies. European Guidelines on Cardiovascular Disease Prevention . Eur J Cardiovasc Preven Rehab2003; 10(suppl1):S1-S78.
4.
Qiao Q., Jousilahti P., Eriksson J., Tuomilehto J.Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes at follow-up. Diabetes Care2003;26:2910-14.
5.
Matz K., Keresztes K., Tatschl C. et al. Disorders of glucose metabolism in acute stroke patients. An underrecognised problem. Diabetes Care2006 ; 29:792-7.
6.
The DECODE Study Group.Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ1998;317:371-75.
7.
Vinik AI, Jenkins DJA.Dietary fiber in management of diabetes. Diabetes Care1998;11:160-73.
8.
Mozaffarian D., Katan MB, Ascherio A. et al. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601-13.
9.
Zaloga GP, Harvey KA, Stillwell W., Siddiqui R.Trans fatty acids and coronary heart disease. Nutr Clin Pract2006;21:505-12.
10.
Sun Q., Ma J., Campos H. et al. A Prospective Study of Trans Fatty Acids in Erythrocytes and Risk of Coronary Heart Disease. Circulation2007, March 26 (Epub ahead of print).
11.
Oomen CM, Ocke MC, Feskens EJ, et al. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet2001;357:746-51.
12.
Stender S., Dyerberg J.The importance of trans-fatty acids for health. Update 2001. Ugeskr Laeger2001;163:2349-53.
13.
New York City Department of Health and Mental Hygiene.Cardiovascular disease prevention. Healthy heart - avoid trans fats. December 5th 2006. http://www.nyc.gov/html/doh/html/cardio/cardiotransfat.shtml (Accessed April 2007).
14.
Food Standards Agency.FSA Nutrient and food based guidelines for UK institutions. October 2006. http://www.food.gov.uk/multimedia/pdfs/nutguideuk.pdf#page=3 , (Accessed April 2007).
15.
Jebb S., Steer T., Holmes C. The `Healthy Living social marketing initiative: A review of the evidence.An independent report commissioned by the Dept of Health. March 2007. http://www.mrc-hnr.cam.ac.uk/downloads/HNR_DH_HealthyLivingReport.pdf (Accessed April 2007).
16.
Buse JB, Ginsberg HN, Bakris GL et al. Primary prevention of cardiovascular disease in people with diabetes mellitus.A scientific statement from the American Heart Association and the American Diabetes Association . Circulation2007;115:114-126 and Diabetes Care2007;30:162-72.
